Cancer Research UK Cambridge Research Institute Standardizes on Phase Forward's InForm(TM) Global Trial Management Solution

WALTHAM, Mass.--(BUSINESS WIRE)--Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced that Cancer Research UK’s Drug Development Office – the drug development arm of the world’s largest independent organization dedicated to cancer research – is standardizing on Phase Forward’s InForm™ Global Trial Management solution to support its diverse portfolio of early-stage clinical trials. The announcement marks a multi-year agreement between Phase Forward and the prestigious research organization.